We are live on ! Find out more
GMED icon

Globus Medical

450 hedge funds and large institutions have $7.72B invested in Globus Medical in 2024 Q2 according to their latest regulatory filings, with 69 funds opening new positions, 136 increasing their positions, 167 reducing their positions, and 55 closing their positions.

New
Increased
Maintained
Reduced
Closed

416% more call options, than puts

Call options by funds: $16.1M | Put options by funds: $3.12M

38% more funds holding in top 10

Funds holding in top 10: 1622 (+6)

27% more capital invested

Capital invested by funds: $6.08B → $7.72B (+$1.64B)

25% more first-time investments, than exits

New positions opened: 69 | Existing positions closed: 55

3% more funds holding

Funds holding: 439450 (+11)

0.32% less ownership

Funds ownership: 100.41%100.09% (-0.32%)

19% less repeat investments, than reductions

Existing positions increased: 136 | Existing positions reduced: 167

Holders
450
Holders Change
+11
Holders Change %
+2.51%
% of All Funds
6.5%
Holding in Top 10
22
Holding in Top 10 Change
+6
Holding in Top 10 Change %
+37.5%
% of All Funds
0.32%
New
69
Increased
136
Reduced
167
Closed
55
Calls
$16.1M
Puts
$3.12M
Net Calls
+$13M
Net Calls Change
+$3.82M
Name Holding Trade Value Shares
Change
Change in
Stake
XWM
226
Xcel Wealth Management
Florida
$943K +$114K +1,914 +16%
MUAMU
227
Mitsubishi UFJ Asset Management (UK)
United Kingdom
$911K -$239K -4,000 -23%
SF
228
Synovus Financial
Georgia
$892K +$33.8K +566 +5%
BCM
229
Bayesian Capital Management
New York
$892K +$329K +5,500 +73%
WSFS
230
Wilmington Savings Fund Society
Delaware
$890K
William Blair & Company
231
William Blair & Company
Illinois
$883K -$41.9K -702 -5%
Neuberger Berman Group
232
Neuberger Berman Group
New York
$854K +$2.45K +41 +0.3%
SOADOR
233
State of Alaska Department of Revenue
Alaska
$853K
GCA
234
Greenwood Capital Associates
South Carolina
$838K +$10K +168 +1%
SG Americas Securities
235
SG Americas Securities
New York
$830K -$299K -5,009 -29%
X
236
Xponance
Pennsylvania
$827K -$300K -5,029 -29%
FTIS
237
First Trust Investment Solutions
Florida
$822K
VPIM
238
Vanguard Personalized Indexing Management
California
$798K +$96.5K +1,616 +16%
YIH
239
Y-Intercept (HK)
Hong Kong
$788K -$238K -3,991 -26%
BCV
240
Banque Cantonale Vaudoise
Switzerland
$787K +$62.3K +1,043 +10%
RJFSA
241
Raymond James Financial Services Advisors
Florida
$786K -$18.5K -309 -3%
Federated Hermes
242
Federated Hermes
Pennsylvania
$783K -$111K -1,863 -14%
SM
243
Sciencast Management
New Jersey
$732K +$639K +10,689 New
CB
244
Commerce Bank
Missouri
$730K
NAM
245
NorthCrest Asset Manangement
Minnesota
$726K
ACIM
246
Azimuth Capital Investment Management
Michigan
$719K -$7.17K -120 -1%
JWS
247
Juncture Wealth Strategies
Arizona
$713K +$218K +3,648 +54%
WCM
248
Washington Capital Management
Washington
$712K
LCM
249
Landscape Capital Management
New Jersey
$680K +$593K +9,929 New
Mitsubishi UFJ Asset Management
250
Mitsubishi UFJ Asset Management
Japan
$678K -$94.5K -1,581 -14%

GMED Hedge Fund Activity: Q2 2024 in Review

450 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Globus Medical (GMED) for Q2 2024, worth a combined $7.72B — up 27% from $6.08B a quarter earlier.

Buyers outnumbered sellers: 69 funds opened new GMED positions and 55 closed out — a net gain of 14 holders — while 136 added to existing stakes and 167 trimmed.

The largest buyer was Select Equity Group, opening a new position worth an estimated $80M. The largest seller was Dimensional Fund Advisors, cutting an estimated $57.1M.

  • 450 institutional investors held Globus Medical (GMED) as of Q2 2024, up from 439 in Q1 2024.
  • Funds reported $7.72B of Globus Medical stock for Q2 2024, up 27% quarter-over-quarter.
  • 69 funds opened new Globus Medical positions in Q2 2024 and 55 closed out, a net change of +14 holders.
  • The largest Globus Medical buyer in Q2 2024 was Select Equity Group, an estimated $80M added.
  • The largest Globus Medical seller in Q2 2024 was Dimensional Fund Advisors, an estimated $57.1M sold.

Based on aggregated 13F filings for Q2 2024.